Hachinski elected president of World Federation of Neurology

Schulich School of Medicine & Dentistry professor Vladimir Hachinski has been elected as the President of the World Federation of Neurology (WFN). (more)

Galenix out-licenses drug delivery technologies to DSM Pharmaceutical Products and forms in a strategic alliance

Galenix today announced that it has out-licensed six drug delivery technologies to DSM Pharmaceutical Products, Parsippany, USA. Galenix and DSM have also agreed on a manufacturing alliance, where DSM will be the preferred commercial scale manufacturing (more)

$2.5 million investment creates new hope for those living with diabetes in Canada

The Lawson Foundation establishes new research Chair (more)

euroPLX Continues to Lead the Way in Pharma Partnering, Announces 2010 Events

Barcelona's leading pharma partnering event facilitates 23 pre-scheduled business negotiations per company. Three confirmed events for 2010. (more)

Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of NEUKINE®, biosimilar form of recombinant GCSF

Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of NEUKINE®, biosimilar form of recombinant GCSF. (more)

Intas Biopharma to pump in Rs 160 cr for dedicated facility for Monoclonal Antibodies (MAbs)

Ahmedabad-based Intas Biopharmaceuticals today said it has signed an MoU with the Gujarat government for setting up a Rs 160 crore facility dedicated to Monoclonal Antibodies (MAbs) at Sanand in Gujarat. (more)

Patient-targeted messaging for Emerging Multiple Sclerosis agents needs to highlight efficacy and preservation of quality of life

Surveyed neurologists perceive the efficacy of Merck Serono’s Rebif nearly as equivalent to that of Biogen Idec’s Tysabri, according to a new report from Decision Resources (more)

Vandervoort lauded for aging research

Faculty of Health Sciences professor Tony Vandervoort has won the prestigious Herbert A. de Vries Research Award for 2010 for distinguished research in the field of aging. (more)

Continued uptake of Tnf-Alpha Inhibitors and Interleukin Inhibitors will drive US $2.2 billion growth in the Psoriasis drug market

Abbott/Eisai’s Humira will achieve blockbuster sales and become the market leader in 2018, according to a new report from Decision Resources (more)

Dr. David Hill receives Frederick G. Banting Award

Dr. David Hill, Scientific Director of the lawson health research Institute has been honoured with the 2009 Federick G. Banting Award for his significant contributions to preventing diabetes in Canada. (more)